Global Geographic Atrophy Treatment Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) that causes a continuous progressive degeneration of the macula. The condition is characterized by widespread atrophy of the outer retinal tissue, retinal pigment epithelium, and choriocapillaris. It typically starts in the perifoveal region and develops to the fovea over time and causing central scotomas and permanent vision loss. Various drugs and treatments are under evaluation.
LPI (LP Information)' newest research report, the “Geographic Atrophy Treatment Industry Forecast” looks at past sales and reviews total world Geographic Atrophy Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Geographic Atrophy Treatment sales for 2023 through 2029. With Geographic Atrophy Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Geographic Atrophy Treatment industry.
This Insight Report provides a comprehensive analysis of the global Geographic Atrophy Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Geographic Atrophy Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Geographic Atrophy Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Geographic Atrophy Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Geographic Atrophy Treatment.
The global Geographic Atrophy Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Geographic Atrophy Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Geographic Atrophy Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Geographic Atrophy Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Geographic Atrophy Treatment players cover Apellis Pharmaceuticals, IVERIC bio, Alkeus Pharmaceuticals, Hemera Biosciences, Allegro Ophthalmics, Stealth BioTherapeutics, Gyroscope Therapeutics, Regenerative Patch Technologies and Roche Holding AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Geographic Atrophy Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) that causes a continuous progressive degeneration of the macula. The condition is characterized by widespread atrophy of the outer retinal tissue, retinal pigment epithelium, and choriocapillaris. It typically starts in the perifoveal region and develops to the fovea over time and causing central scotomas and permanent vision loss. Various drugs and treatments are under evaluation.
LPI (LP Information)' newest research report, the “Geographic Atrophy Treatment Industry Forecast” looks at past sales and reviews total world Geographic Atrophy Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Geographic Atrophy Treatment sales for 2023 through 2029. With Geographic Atrophy Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Geographic Atrophy Treatment industry.
This Insight Report provides a comprehensive analysis of the global Geographic Atrophy Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Geographic Atrophy Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Geographic Atrophy Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Geographic Atrophy Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Geographic Atrophy Treatment.
The global Geographic Atrophy Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Geographic Atrophy Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Geographic Atrophy Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Geographic Atrophy Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Geographic Atrophy Treatment players cover Apellis Pharmaceuticals, IVERIC bio, Alkeus Pharmaceuticals, Hemera Biosciences, Allegro Ophthalmics, Stealth BioTherapeutics, Gyroscope Therapeutics, Regenerative Patch Technologies and Roche Holding AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Geographic Atrophy Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Late-stage (Phase III) Treatment
- Phase II Treatment
- Phase I Treatment
- Pre-Clinical Stage Treatment
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Apellis Pharmaceuticals
- IVERIC bio
- Alkeus Pharmaceuticals
- Hemera Biosciences
- Allegro Ophthalmics
- Stealth BioTherapeutics
- Gyroscope Therapeutics
- Regenerative Patch Technologies
- Roche Holding AG
- Gensight Biologics SA
- NGM Biopharmaceuticals
- AstraZeneca
- Lineage Cell Therapeutics
- Allergan
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Geographic Atrophy Treatment Market Size 2018-2029
2.1.2 Geographic Atrophy Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Geographic Atrophy Treatment Segment by Type
2.2.1 Late-stage (Phase III) Treatment
2.2.2 Phase II Treatment
2.2.3 Phase I Treatment
2.2.4 Pre-Clinical Stage Treatment
2.3 Geographic Atrophy Treatment Market Size by Type
2.3.1 Geographic Atrophy Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Geographic Atrophy Treatment Market Size Market Share by Type (2018-2023)
2.4 Geographic Atrophy Treatment Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Geographic Atrophy Treatment Market Size by Application
2.5.1 Geographic Atrophy Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Geographic Atrophy Treatment Market Size Market Share by Application (2018-2023)
3 GEOGRAPHIC ATROPHY TREATMENT MARKET SIZE BY PLAYER
3.1 Geographic Atrophy Treatment Market Size Market Share by Players
3.1.1 Global Geographic Atrophy Treatment Revenue by Players (2018-2023)
3.1.2 Global Geographic Atrophy Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Geographic Atrophy Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GEOGRAPHIC ATROPHY TREATMENT BY REGIONS
4.1 Geographic Atrophy Treatment Market Size by Regions (2018-2023)
4.2 Americas Geographic Atrophy Treatment Market Size Growth (2018-2023)
4.3 APAC Geographic Atrophy Treatment Market Size Growth (2018-2023)
4.4 Europe Geographic Atrophy Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Geographic Atrophy Treatment Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Geographic Atrophy Treatment Market Size by Country (2018-2023)
5.2 Americas Geographic Atrophy Treatment Market Size by Type (2018-2023)
5.3 Americas Geographic Atrophy Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Geographic Atrophy Treatment Market Size by Region (2018-2023)
6.2 APAC Geographic Atrophy Treatment Market Size by Type (2018-2023)
6.3 APAC Geographic Atrophy Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Geographic Atrophy Treatment by Country (2018-2023)
7.2 Europe Geographic Atrophy Treatment Market Size by Type (2018-2023)
7.3 Europe Geographic Atrophy Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Geographic Atrophy Treatment by Region (2018-2023)
8.2 Middle East & Africa Geographic Atrophy Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Geographic Atrophy Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GEOGRAPHIC ATROPHY TREATMENT MARKET FORECAST
10.1 Global Geographic Atrophy Treatment Forecast by Regions (2024-2029)
10.1.1 Global Geographic Atrophy Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Geographic Atrophy Treatment Forecast
10.1.3 APAC Geographic Atrophy Treatment Forecast
10.1.4 Europe Geographic Atrophy Treatment Forecast
10.1.5 Middle East & Africa Geographic Atrophy Treatment Forecast
10.2 Americas Geographic Atrophy Treatment Forecast by Country (2024-2029)
10.2.1 United States Geographic Atrophy Treatment Market Forecast
10.2.2 Canada Geographic Atrophy Treatment Market Forecast
10.2.3 Mexico Geographic Atrophy Treatment Market Forecast
10.2.4 Brazil Geographic Atrophy Treatment Market Forecast
10.3 APAC Geographic Atrophy Treatment Forecast by Region (2024-2029)
10.3.1 China Geographic Atrophy Treatment Market Forecast
10.3.2 Japan Geographic Atrophy Treatment Market Forecast
10.3.3 Korea Geographic Atrophy Treatment Market Forecast
10.3.4 Southeast Asia Geographic Atrophy Treatment Market Forecast
10.3.5 India Geographic Atrophy Treatment Market Forecast
10.3.6 Australia Geographic Atrophy Treatment Market Forecast
10.4 Europe Geographic Atrophy Treatment Forecast by Country (2024-2029)
10.4.1 Germany Geographic Atrophy Treatment Market Forecast
10.4.2 France Geographic Atrophy Treatment Market Forecast
10.4.3 UK Geographic Atrophy Treatment Market Forecast
10.4.4 Italy Geographic Atrophy Treatment Market Forecast
10.4.5 Russia Geographic Atrophy Treatment Market Forecast
10.5 Middle East & Africa Geographic Atrophy Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Geographic Atrophy Treatment Market Forecast
10.5.2 South Africa Geographic Atrophy Treatment Market Forecast
10.5.3 Israel Geographic Atrophy Treatment Market Forecast
10.5.4 Turkey Geographic Atrophy Treatment Market Forecast
10.5.5 GCC Countries Geographic Atrophy Treatment Market Forecast
10.6 Global Geographic Atrophy Treatment Forecast by Type (2024-2029)
10.7 Global Geographic Atrophy Treatment Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Apellis Pharmaceuticals
11.1.1 Apellis Pharmaceuticals Company Information
11.1.2 Apellis Pharmaceuticals Geographic Atrophy Treatment Product Offered
11.1.3 Apellis Pharmaceuticals Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Apellis Pharmaceuticals Main Business Overview
11.1.5 Apellis Pharmaceuticals Latest Developments
11.2 IVERIC bio
11.2.1 IVERIC bio Company Information
11.2.2 IVERIC bio Geographic Atrophy Treatment Product Offered
11.2.3 IVERIC bio Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 IVERIC bio Main Business Overview
11.2.5 IVERIC bio Latest Developments
11.3 Alkeus Pharmaceuticals
11.3.1 Alkeus Pharmaceuticals Company Information
11.3.2 Alkeus Pharmaceuticals Geographic Atrophy Treatment Product Offered
11.3.3 Alkeus Pharmaceuticals Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Alkeus Pharmaceuticals Main Business Overview
11.3.5 Alkeus Pharmaceuticals Latest Developments
11.4 Hemera Biosciences
11.4.1 Hemera Biosciences Company Information
11.4.2 Hemera Biosciences Geographic Atrophy Treatment Product Offered
11.4.3 Hemera Biosciences Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Hemera Biosciences Main Business Overview
11.4.5 Hemera Biosciences Latest Developments
11.5 Allegro Ophthalmics
11.5.1 Allegro Ophthalmics Company Information
11.5.2 Allegro Ophthalmics Geographic Atrophy Treatment Product Offered
11.5.3 Allegro Ophthalmics Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Allegro Ophthalmics Main Business Overview
11.5.5 Allegro Ophthalmics Latest Developments
11.6 Stealth BioTherapeutics
11.6.1 Stealth BioTherapeutics Company Information
11.6.2 Stealth BioTherapeutics Geographic Atrophy Treatment Product Offered
11.6.3 Stealth BioTherapeutics Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Stealth BioTherapeutics Main Business Overview
11.6.5 Stealth BioTherapeutics Latest Developments
11.7 Gyroscope Therapeutics
11.7.1 Gyroscope Therapeutics Company Information
11.7.2 Gyroscope Therapeutics Geographic Atrophy Treatment Product Offered
11.7.3 Gyroscope Therapeutics Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Gyroscope Therapeutics Main Business Overview
11.7.5 Gyroscope Therapeutics Latest Developments
11.8 Regenerative Patch Technologies
11.8.1 Regenerative Patch Technologies Company Information
11.8.2 Regenerative Patch Technologies Geographic Atrophy Treatment Product Offered
11.8.3 Regenerative Patch Technologies Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Regenerative Patch Technologies Main Business Overview
11.8.5 Regenerative Patch Technologies Latest Developments
11.9 Roche Holding AG
11.9.1 Roche Holding AG Company Information
11.9.2 Roche Holding AG Geographic Atrophy Treatment Product Offered
11.9.3 Roche Holding AG Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Roche Holding AG Main Business Overview
11.9.5 Roche Holding AG Latest Developments
11.10 Gensight Biologics SA
11.10.1 Gensight Biologics SA Company Information
11.10.2 Gensight Biologics SA Geographic Atrophy Treatment Product Offered
11.10.3 Gensight Biologics SA Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Gensight Biologics SA Main Business Overview
11.10.5 Gensight Biologics SA Latest Developments
11.11 NGM Biopharmaceuticals
11.11.1 NGM Biopharmaceuticals Company Information
11.11.2 NGM Biopharmaceuticals Geographic Atrophy Treatment Product Offered
11.11.3 NGM Biopharmaceuticals Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 NGM Biopharmaceuticals Main Business Overview
11.11.5 NGM Biopharmaceuticals Latest Developments
11.12 AstraZeneca
11.12.1 AstraZeneca Company Information
11.12.2 AstraZeneca Geographic Atrophy Treatment Product Offered
11.12.3 AstraZeneca Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 AstraZeneca Main Business Overview
11.12.5 AstraZeneca Latest Developments
11.13 Lineage Cell Therapeutics
11.13.1 Lineage Cell Therapeutics Company Information
11.13.2 Lineage Cell Therapeutics Geographic Atrophy Treatment Product Offered
11.13.3 Lineage Cell Therapeutics Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Lineage Cell Therapeutics Main Business Overview
11.13.5 Lineage Cell Therapeutics Latest Developments
11.14 Allergan
11.14.1 Allergan Company Information
11.14.2 Allergan Geographic Atrophy Treatment Product Offered
11.14.3 Allergan Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Allergan Main Business Overview
11.14.5 Allergan Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Geographic Atrophy Treatment Market Size 2018-2029
2.1.2 Geographic Atrophy Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Geographic Atrophy Treatment Segment by Type
2.2.1 Late-stage (Phase III) Treatment
2.2.2 Phase II Treatment
2.2.3 Phase I Treatment
2.2.4 Pre-Clinical Stage Treatment
2.3 Geographic Atrophy Treatment Market Size by Type
2.3.1 Geographic Atrophy Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Geographic Atrophy Treatment Market Size Market Share by Type (2018-2023)
2.4 Geographic Atrophy Treatment Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Geographic Atrophy Treatment Market Size by Application
2.5.1 Geographic Atrophy Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Geographic Atrophy Treatment Market Size Market Share by Application (2018-2023)
3 GEOGRAPHIC ATROPHY TREATMENT MARKET SIZE BY PLAYER
3.1 Geographic Atrophy Treatment Market Size Market Share by Players
3.1.1 Global Geographic Atrophy Treatment Revenue by Players (2018-2023)
3.1.2 Global Geographic Atrophy Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Geographic Atrophy Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GEOGRAPHIC ATROPHY TREATMENT BY REGIONS
4.1 Geographic Atrophy Treatment Market Size by Regions (2018-2023)
4.2 Americas Geographic Atrophy Treatment Market Size Growth (2018-2023)
4.3 APAC Geographic Atrophy Treatment Market Size Growth (2018-2023)
4.4 Europe Geographic Atrophy Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Geographic Atrophy Treatment Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Geographic Atrophy Treatment Market Size by Country (2018-2023)
5.2 Americas Geographic Atrophy Treatment Market Size by Type (2018-2023)
5.3 Americas Geographic Atrophy Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Geographic Atrophy Treatment Market Size by Region (2018-2023)
6.2 APAC Geographic Atrophy Treatment Market Size by Type (2018-2023)
6.3 APAC Geographic Atrophy Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Geographic Atrophy Treatment by Country (2018-2023)
7.2 Europe Geographic Atrophy Treatment Market Size by Type (2018-2023)
7.3 Europe Geographic Atrophy Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Geographic Atrophy Treatment by Region (2018-2023)
8.2 Middle East & Africa Geographic Atrophy Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Geographic Atrophy Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GEOGRAPHIC ATROPHY TREATMENT MARKET FORECAST
10.1 Global Geographic Atrophy Treatment Forecast by Regions (2024-2029)
10.1.1 Global Geographic Atrophy Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Geographic Atrophy Treatment Forecast
10.1.3 APAC Geographic Atrophy Treatment Forecast
10.1.4 Europe Geographic Atrophy Treatment Forecast
10.1.5 Middle East & Africa Geographic Atrophy Treatment Forecast
10.2 Americas Geographic Atrophy Treatment Forecast by Country (2024-2029)
10.2.1 United States Geographic Atrophy Treatment Market Forecast
10.2.2 Canada Geographic Atrophy Treatment Market Forecast
10.2.3 Mexico Geographic Atrophy Treatment Market Forecast
10.2.4 Brazil Geographic Atrophy Treatment Market Forecast
10.3 APAC Geographic Atrophy Treatment Forecast by Region (2024-2029)
10.3.1 China Geographic Atrophy Treatment Market Forecast
10.3.2 Japan Geographic Atrophy Treatment Market Forecast
10.3.3 Korea Geographic Atrophy Treatment Market Forecast
10.3.4 Southeast Asia Geographic Atrophy Treatment Market Forecast
10.3.5 India Geographic Atrophy Treatment Market Forecast
10.3.6 Australia Geographic Atrophy Treatment Market Forecast
10.4 Europe Geographic Atrophy Treatment Forecast by Country (2024-2029)
10.4.1 Germany Geographic Atrophy Treatment Market Forecast
10.4.2 France Geographic Atrophy Treatment Market Forecast
10.4.3 UK Geographic Atrophy Treatment Market Forecast
10.4.4 Italy Geographic Atrophy Treatment Market Forecast
10.4.5 Russia Geographic Atrophy Treatment Market Forecast
10.5 Middle East & Africa Geographic Atrophy Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Geographic Atrophy Treatment Market Forecast
10.5.2 South Africa Geographic Atrophy Treatment Market Forecast
10.5.3 Israel Geographic Atrophy Treatment Market Forecast
10.5.4 Turkey Geographic Atrophy Treatment Market Forecast
10.5.5 GCC Countries Geographic Atrophy Treatment Market Forecast
10.6 Global Geographic Atrophy Treatment Forecast by Type (2024-2029)
10.7 Global Geographic Atrophy Treatment Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Apellis Pharmaceuticals
11.1.1 Apellis Pharmaceuticals Company Information
11.1.2 Apellis Pharmaceuticals Geographic Atrophy Treatment Product Offered
11.1.3 Apellis Pharmaceuticals Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Apellis Pharmaceuticals Main Business Overview
11.1.5 Apellis Pharmaceuticals Latest Developments
11.2 IVERIC bio
11.2.1 IVERIC bio Company Information
11.2.2 IVERIC bio Geographic Atrophy Treatment Product Offered
11.2.3 IVERIC bio Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 IVERIC bio Main Business Overview
11.2.5 IVERIC bio Latest Developments
11.3 Alkeus Pharmaceuticals
11.3.1 Alkeus Pharmaceuticals Company Information
11.3.2 Alkeus Pharmaceuticals Geographic Atrophy Treatment Product Offered
11.3.3 Alkeus Pharmaceuticals Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Alkeus Pharmaceuticals Main Business Overview
11.3.5 Alkeus Pharmaceuticals Latest Developments
11.4 Hemera Biosciences
11.4.1 Hemera Biosciences Company Information
11.4.2 Hemera Biosciences Geographic Atrophy Treatment Product Offered
11.4.3 Hemera Biosciences Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Hemera Biosciences Main Business Overview
11.4.5 Hemera Biosciences Latest Developments
11.5 Allegro Ophthalmics
11.5.1 Allegro Ophthalmics Company Information
11.5.2 Allegro Ophthalmics Geographic Atrophy Treatment Product Offered
11.5.3 Allegro Ophthalmics Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Allegro Ophthalmics Main Business Overview
11.5.5 Allegro Ophthalmics Latest Developments
11.6 Stealth BioTherapeutics
11.6.1 Stealth BioTherapeutics Company Information
11.6.2 Stealth BioTherapeutics Geographic Atrophy Treatment Product Offered
11.6.3 Stealth BioTherapeutics Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Stealth BioTherapeutics Main Business Overview
11.6.5 Stealth BioTherapeutics Latest Developments
11.7 Gyroscope Therapeutics
11.7.1 Gyroscope Therapeutics Company Information
11.7.2 Gyroscope Therapeutics Geographic Atrophy Treatment Product Offered
11.7.3 Gyroscope Therapeutics Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Gyroscope Therapeutics Main Business Overview
11.7.5 Gyroscope Therapeutics Latest Developments
11.8 Regenerative Patch Technologies
11.8.1 Regenerative Patch Technologies Company Information
11.8.2 Regenerative Patch Technologies Geographic Atrophy Treatment Product Offered
11.8.3 Regenerative Patch Technologies Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Regenerative Patch Technologies Main Business Overview
11.8.5 Regenerative Patch Technologies Latest Developments
11.9 Roche Holding AG
11.9.1 Roche Holding AG Company Information
11.9.2 Roche Holding AG Geographic Atrophy Treatment Product Offered
11.9.3 Roche Holding AG Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Roche Holding AG Main Business Overview
11.9.5 Roche Holding AG Latest Developments
11.10 Gensight Biologics SA
11.10.1 Gensight Biologics SA Company Information
11.10.2 Gensight Biologics SA Geographic Atrophy Treatment Product Offered
11.10.3 Gensight Biologics SA Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Gensight Biologics SA Main Business Overview
11.10.5 Gensight Biologics SA Latest Developments
11.11 NGM Biopharmaceuticals
11.11.1 NGM Biopharmaceuticals Company Information
11.11.2 NGM Biopharmaceuticals Geographic Atrophy Treatment Product Offered
11.11.3 NGM Biopharmaceuticals Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 NGM Biopharmaceuticals Main Business Overview
11.11.5 NGM Biopharmaceuticals Latest Developments
11.12 AstraZeneca
11.12.1 AstraZeneca Company Information
11.12.2 AstraZeneca Geographic Atrophy Treatment Product Offered
11.12.3 AstraZeneca Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 AstraZeneca Main Business Overview
11.12.5 AstraZeneca Latest Developments
11.13 Lineage Cell Therapeutics
11.13.1 Lineage Cell Therapeutics Company Information
11.13.2 Lineage Cell Therapeutics Geographic Atrophy Treatment Product Offered
11.13.3 Lineage Cell Therapeutics Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Lineage Cell Therapeutics Main Business Overview
11.13.5 Lineage Cell Therapeutics Latest Developments
11.14 Allergan
11.14.1 Allergan Company Information
11.14.2 Allergan Geographic Atrophy Treatment Product Offered
11.14.3 Allergan Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Allergan Main Business Overview
11.14.5 Allergan Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Geographic Atrophy Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Late-stage (Phase III) Treatment
Table 3. Major Players of Phase II Treatment
Table 4. Major Players of Phase I Treatment
Table 5. Major Players of Pre-Clinical Stage Treatment
Table 6. Geographic Atrophy Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Geographic Atrophy Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Geographic Atrophy Treatment Market Size Market Share by Type (2018-2023)
Table 9. Geographic Atrophy Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Geographic Atrophy Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Geographic Atrophy Treatment Market Size Market Share by Application (2018-2023)
Table 12. Global Geographic Atrophy Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Geographic Atrophy Treatment Revenue Market Share by Player (2018-2023)
Table 14. Geographic Atrophy Treatment Key Players Head office and Products Offered
Table 15. Geographic Atrophy Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Geographic Atrophy Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Geographic Atrophy Treatment Market Size Market Share by Regions (2018-2023)
Table 20. Global Geographic Atrophy Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Geographic Atrophy Treatment Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Geographic Atrophy Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Geographic Atrophy Treatment Market Size Market Share by Country (2018-2023)
Table 24. Americas Geographic Atrophy Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Geographic Atrophy Treatment Market Size Market Share by Type (2018-2023)
Table 26. Americas Geographic Atrophy Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Geographic Atrophy Treatment Market Size Market Share by Application (2018-2023)
Table 28. APAC Geographic Atrophy Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Geographic Atrophy Treatment Market Size Market Share by Region (2018-2023)
Table 30. APAC Geographic Atrophy Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Geographic Atrophy Treatment Market Size Market Share by Type (2018-2023)
Table 32. APAC Geographic Atrophy Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Geographic Atrophy Treatment Market Size Market Share by Application (2018-2023)
Table 34. Europe Geographic Atrophy Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Geographic Atrophy Treatment Market Size Market Share by Country (2018-2023)
Table 36. Europe Geographic Atrophy Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Geographic Atrophy Treatment Market Size Market Share by Type (2018-2023)
Table 38. Europe Geographic Atrophy Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Geographic Atrophy Treatment Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Geographic Atrophy Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Geographic Atrophy Treatment Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Geographic Atrophy Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Geographic Atrophy Treatment Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Geographic Atrophy Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Geographic Atrophy Treatment Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Geographic Atrophy Treatment
Table 47. Key Market Challenges & Risks of Geographic Atrophy Treatment
Table 48. Key Industry Trends of Geographic Atrophy Treatment
Table 49. Global Geographic Atrophy Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Geographic Atrophy Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Geographic Atrophy Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Geographic Atrophy Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Apellis Pharmaceuticals Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 54. Apellis Pharmaceuticals Geographic Atrophy Treatment Product Offered
Table 55. Apellis Pharmaceuticals Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Apellis Pharmaceuticals Main Business
Table 57. Apellis Pharmaceuticals Latest Developments
Table 58. IVERIC bio Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 59. IVERIC bio Geographic Atrophy Treatment Product Offered
Table 60. IVERIC bio Main Business
Table 61. IVERIC bio Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. IVERIC bio Latest Developments
Table 63. Alkeus Pharmaceuticals Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 64. Alkeus Pharmaceuticals Geographic Atrophy Treatment Product Offered
Table 65. Alkeus Pharmaceuticals Main Business
Table 66. Alkeus Pharmaceuticals Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Alkeus Pharmaceuticals Latest Developments
Table 68. Hemera Biosciences Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 69. Hemera Biosciences Geographic Atrophy Treatment Product Offered
Table 70. Hemera Biosciences Main Business
Table 71. Hemera Biosciences Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Hemera Biosciences Latest Developments
Table 73. Allegro Ophthalmics Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 74. Allegro Ophthalmics Geographic Atrophy Treatment Product Offered
Table 75. Allegro Ophthalmics Main Business
Table 76. Allegro Ophthalmics Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Allegro Ophthalmics Latest Developments
Table 78. Stealth BioTherapeutics Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 79. Stealth BioTherapeutics Geographic Atrophy Treatment Product Offered
Table 80. Stealth BioTherapeutics Main Business
Table 81. Stealth BioTherapeutics Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Stealth BioTherapeutics Latest Developments
Table 83. Gyroscope Therapeutics Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 84. Gyroscope Therapeutics Geographic Atrophy Treatment Product Offered
Table 85. Gyroscope Therapeutics Main Business
Table 86. Gyroscope Therapeutics Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Gyroscope Therapeutics Latest Developments
Table 88. Regenerative Patch Technologies Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 89. Regenerative Patch Technologies Geographic Atrophy Treatment Product Offered
Table 90. Regenerative Patch Technologies Main Business
Table 91. Regenerative Patch Technologies Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Regenerative Patch Technologies Latest Developments
Table 93. Roche Holding AG Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 94. Roche Holding AG Geographic Atrophy Treatment Product Offered
Table 95. Roche Holding AG Main Business
Table 96. Roche Holding AG Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Roche Holding AG Latest Developments
Table 98. Gensight Biologics SA Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 99. Gensight Biologics SA Geographic Atrophy Treatment Product Offered
Table 100. Gensight Biologics SA Main Business
Table 101. Gensight Biologics SA Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Gensight Biologics SA Latest Developments
Table 103. NGM Biopharmaceuticals Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 104. NGM Biopharmaceuticals Geographic Atrophy Treatment Product Offered
Table 105. NGM Biopharmaceuticals Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. NGM Biopharmaceuticals Main Business
Table 107. NGM Biopharmaceuticals Latest Developments
Table 108. AstraZeneca Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 109. AstraZeneca Geographic Atrophy Treatment Product Offered
Table 110. AstraZeneca Main Business
Table 111. AstraZeneca Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. AstraZeneca Latest Developments
Table 113. Lineage Cell Therapeutics Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 114. Lineage Cell Therapeutics Geographic Atrophy Treatment Product Offered
Table 115. Lineage Cell Therapeutics Main Business
Table 116. Lineage Cell Therapeutics Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Lineage Cell Therapeutics Latest Developments
Table 118. Allergan Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 119. Allergan Geographic Atrophy Treatment Product Offered
Table 120. Allergan Main Business
Table 121. Allergan Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Allergan Latest Developments
Table 1. Geographic Atrophy Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Late-stage (Phase III) Treatment
Table 3. Major Players of Phase II Treatment
Table 4. Major Players of Phase I Treatment
Table 5. Major Players of Pre-Clinical Stage Treatment
Table 6. Geographic Atrophy Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Geographic Atrophy Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Geographic Atrophy Treatment Market Size Market Share by Type (2018-2023)
Table 9. Geographic Atrophy Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Geographic Atrophy Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Geographic Atrophy Treatment Market Size Market Share by Application (2018-2023)
Table 12. Global Geographic Atrophy Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Geographic Atrophy Treatment Revenue Market Share by Player (2018-2023)
Table 14. Geographic Atrophy Treatment Key Players Head office and Products Offered
Table 15. Geographic Atrophy Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Geographic Atrophy Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Geographic Atrophy Treatment Market Size Market Share by Regions (2018-2023)
Table 20. Global Geographic Atrophy Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Geographic Atrophy Treatment Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Geographic Atrophy Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Geographic Atrophy Treatment Market Size Market Share by Country (2018-2023)
Table 24. Americas Geographic Atrophy Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Geographic Atrophy Treatment Market Size Market Share by Type (2018-2023)
Table 26. Americas Geographic Atrophy Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Geographic Atrophy Treatment Market Size Market Share by Application (2018-2023)
Table 28. APAC Geographic Atrophy Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Geographic Atrophy Treatment Market Size Market Share by Region (2018-2023)
Table 30. APAC Geographic Atrophy Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Geographic Atrophy Treatment Market Size Market Share by Type (2018-2023)
Table 32. APAC Geographic Atrophy Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Geographic Atrophy Treatment Market Size Market Share by Application (2018-2023)
Table 34. Europe Geographic Atrophy Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Geographic Atrophy Treatment Market Size Market Share by Country (2018-2023)
Table 36. Europe Geographic Atrophy Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Geographic Atrophy Treatment Market Size Market Share by Type (2018-2023)
Table 38. Europe Geographic Atrophy Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Geographic Atrophy Treatment Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Geographic Atrophy Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Geographic Atrophy Treatment Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Geographic Atrophy Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Geographic Atrophy Treatment Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Geographic Atrophy Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Geographic Atrophy Treatment Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Geographic Atrophy Treatment
Table 47. Key Market Challenges & Risks of Geographic Atrophy Treatment
Table 48. Key Industry Trends of Geographic Atrophy Treatment
Table 49. Global Geographic Atrophy Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Geographic Atrophy Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Geographic Atrophy Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Geographic Atrophy Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Apellis Pharmaceuticals Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 54. Apellis Pharmaceuticals Geographic Atrophy Treatment Product Offered
Table 55. Apellis Pharmaceuticals Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Apellis Pharmaceuticals Main Business
Table 57. Apellis Pharmaceuticals Latest Developments
Table 58. IVERIC bio Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 59. IVERIC bio Geographic Atrophy Treatment Product Offered
Table 60. IVERIC bio Main Business
Table 61. IVERIC bio Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. IVERIC bio Latest Developments
Table 63. Alkeus Pharmaceuticals Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 64. Alkeus Pharmaceuticals Geographic Atrophy Treatment Product Offered
Table 65. Alkeus Pharmaceuticals Main Business
Table 66. Alkeus Pharmaceuticals Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Alkeus Pharmaceuticals Latest Developments
Table 68. Hemera Biosciences Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 69. Hemera Biosciences Geographic Atrophy Treatment Product Offered
Table 70. Hemera Biosciences Main Business
Table 71. Hemera Biosciences Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Hemera Biosciences Latest Developments
Table 73. Allegro Ophthalmics Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 74. Allegro Ophthalmics Geographic Atrophy Treatment Product Offered
Table 75. Allegro Ophthalmics Main Business
Table 76. Allegro Ophthalmics Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Allegro Ophthalmics Latest Developments
Table 78. Stealth BioTherapeutics Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 79. Stealth BioTherapeutics Geographic Atrophy Treatment Product Offered
Table 80. Stealth BioTherapeutics Main Business
Table 81. Stealth BioTherapeutics Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Stealth BioTherapeutics Latest Developments
Table 83. Gyroscope Therapeutics Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 84. Gyroscope Therapeutics Geographic Atrophy Treatment Product Offered
Table 85. Gyroscope Therapeutics Main Business
Table 86. Gyroscope Therapeutics Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Gyroscope Therapeutics Latest Developments
Table 88. Regenerative Patch Technologies Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 89. Regenerative Patch Technologies Geographic Atrophy Treatment Product Offered
Table 90. Regenerative Patch Technologies Main Business
Table 91. Regenerative Patch Technologies Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Regenerative Patch Technologies Latest Developments
Table 93. Roche Holding AG Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 94. Roche Holding AG Geographic Atrophy Treatment Product Offered
Table 95. Roche Holding AG Main Business
Table 96. Roche Holding AG Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Roche Holding AG Latest Developments
Table 98. Gensight Biologics SA Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 99. Gensight Biologics SA Geographic Atrophy Treatment Product Offered
Table 100. Gensight Biologics SA Main Business
Table 101. Gensight Biologics SA Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Gensight Biologics SA Latest Developments
Table 103. NGM Biopharmaceuticals Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 104. NGM Biopharmaceuticals Geographic Atrophy Treatment Product Offered
Table 105. NGM Biopharmaceuticals Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. NGM Biopharmaceuticals Main Business
Table 107. NGM Biopharmaceuticals Latest Developments
Table 108. AstraZeneca Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 109. AstraZeneca Geographic Atrophy Treatment Product Offered
Table 110. AstraZeneca Main Business
Table 111. AstraZeneca Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. AstraZeneca Latest Developments
Table 113. Lineage Cell Therapeutics Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 114. Lineage Cell Therapeutics Geographic Atrophy Treatment Product Offered
Table 115. Lineage Cell Therapeutics Main Business
Table 116. Lineage Cell Therapeutics Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Lineage Cell Therapeutics Latest Developments
Table 118. Allergan Details, Company Type, Geographic Atrophy Treatment Area Served and Its Competitors
Table 119. Allergan Geographic Atrophy Treatment Product Offered
Table 120. Allergan Main Business
Table 121. Allergan Geographic Atrophy Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Allergan Latest Developments
LIST OF FIGURES
Figure 1. Geographic Atrophy Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Geographic Atrophy Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Geographic Atrophy Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Geographic Atrophy Treatment Sales Market Share by Country/Region (2022)
Figure 8. Geographic Atrophy Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Geographic Atrophy Treatment Market Size Market Share by Type in 2022
Figure 10. Geographic Atrophy Treatment in Hospital
Figure 11. Global Geographic Atrophy Treatment Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Geographic Atrophy Treatment in Clinic
Figure 13. Global Geographic Atrophy Treatment Market: Clinic (2018-2023) & ($ Millions)
Figure 14. Global Geographic Atrophy Treatment Market Size Market Share by Application in 2022
Figure 15. Global Geographic Atrophy Treatment Revenue Market Share by Player in 2022
Figure 16. Global Geographic Atrophy Treatment Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Geographic Atrophy Treatment Market Size 2018-2023 ($ Millions)
Figure 18. APAC Geographic Atrophy Treatment Market Size 2018-2023 ($ Millions)
Figure 19. Europe Geographic Atrophy Treatment Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Geographic Atrophy Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Americas Geographic Atrophy Treatment Value Market Share by Country in 2022
Figure 22. United States Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Geographic Atrophy Treatment Market Size Market Share by Region in 2022
Figure 27. APAC Geographic Atrophy Treatment Market Size Market Share by Type in 2022
Figure 28. APAC Geographic Atrophy Treatment Market Size Market Share by Application in 2022
Figure 29. China Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Geographic Atrophy Treatment Market Size Market Share by Country in 2022
Figure 36. Europe Geographic Atrophy Treatment Market Size Market Share by Type (2018-2023)
Figure 37. Europe Geographic Atrophy Treatment Market Size Market Share by Application (2018-2023)
Figure 38. Germany Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Geographic Atrophy Treatment Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Geographic Atrophy Treatment Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Geographic Atrophy Treatment Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 52. APAC Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 53. Europe Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 55. United States Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Canada Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 59. China Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Japan Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 61. Korea Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 63. India Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Australia Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 65. Germany Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 66. France Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 67. UK Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 68. Italy Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 69. Russia Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Spain Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Israel Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Global Geographic Atrophy Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Geographic Atrophy Treatment Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Geographic Atrophy Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Geographic Atrophy Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Geographic Atrophy Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Geographic Atrophy Treatment Sales Market Share by Country/Region (2022)
Figure 8. Geographic Atrophy Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Geographic Atrophy Treatment Market Size Market Share by Type in 2022
Figure 10. Geographic Atrophy Treatment in Hospital
Figure 11. Global Geographic Atrophy Treatment Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Geographic Atrophy Treatment in Clinic
Figure 13. Global Geographic Atrophy Treatment Market: Clinic (2018-2023) & ($ Millions)
Figure 14. Global Geographic Atrophy Treatment Market Size Market Share by Application in 2022
Figure 15. Global Geographic Atrophy Treatment Revenue Market Share by Player in 2022
Figure 16. Global Geographic Atrophy Treatment Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Geographic Atrophy Treatment Market Size 2018-2023 ($ Millions)
Figure 18. APAC Geographic Atrophy Treatment Market Size 2018-2023 ($ Millions)
Figure 19. Europe Geographic Atrophy Treatment Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Geographic Atrophy Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Americas Geographic Atrophy Treatment Value Market Share by Country in 2022
Figure 22. United States Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Geographic Atrophy Treatment Market Size Market Share by Region in 2022
Figure 27. APAC Geographic Atrophy Treatment Market Size Market Share by Type in 2022
Figure 28. APAC Geographic Atrophy Treatment Market Size Market Share by Application in 2022
Figure 29. China Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Geographic Atrophy Treatment Market Size Market Share by Country in 2022
Figure 36. Europe Geographic Atrophy Treatment Market Size Market Share by Type (2018-2023)
Figure 37. Europe Geographic Atrophy Treatment Market Size Market Share by Application (2018-2023)
Figure 38. Germany Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Geographic Atrophy Treatment Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Geographic Atrophy Treatment Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Geographic Atrophy Treatment Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Geographic Atrophy Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 52. APAC Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 53. Europe Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 55. United States Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Canada Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 59. China Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Japan Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 61. Korea Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 63. India Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Australia Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 65. Germany Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 66. France Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 67. UK Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 68. Italy Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 69. Russia Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Spain Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Israel Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Geographic Atrophy Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Global Geographic Atrophy Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Geographic Atrophy Treatment Market Size Market Share Forecast by Application (2024-2029)
